Arecor Therapeutics PLC Registered Shares LS -,01
- BID
0.705
- ASK
0.78
- 2,837 Units2,564 Units
- 07/21, 17:29:02 PM
Sector and Industry
Healthcare, Healthcare Services
Performance (1Y)
91.99%
Market Cap
-
P/E Ratio
45.74
Dividend Yield
0.00 %
Earnings per Share
0.02 €
Peer Group
| Company Name | Market Cap | Revenue Last Reported Year | P/E Ratio | Profit Growth 1Y | Last Price | Previous Trading Day Change |
|---|---|---|---|---|---|---|
| UnitedHealth Group Inc. | 254.66 Bil. | 396.73 Bil. | 24.94 | -19.75 % | 0.00 | - |
| Thermo Fisher Scientific Inc. | 185.62 Bil. | 39.50 Bil. | 32.67 | +1.45 % | 0.00 | - |
| Danaher Corp. | 137.79 Bil. | 21.78 Bil. | 45.36 | -11.47 % | 0.00 | - |
| McKesson Corporation | 90.13 Bil. | 348.09 Bil. | 22.55 | +33.83 % | 0.00 | - |
| HCA Healthcare Inc. | 89.28 Bil. | 67.01 Bil. | 16.48 | +12.93 % | 0.00 | - |
| Elevance Health Inc. | 65.88 Bil. | 176.51 Bil. | 13.91 | -9.22 % | 0.00 | - |
| The Cigna Group | 61.74 Bil. | 243.65 Bil. | 12.41 | +66.33 % | 0.00 | - |
| Cencora Inc. | 51.58 Bil. | 291.15 Bil. | 39.26 | +1.16 % | 0.00 | - |
| IDEXX Laboratories Inc. | 45.92 Bil. | 3.81 Bil. | 51.74 | +14.41 % | 0.00 | - |
| Zoetis Inc. | 45.52 Bil. | 8.39 Bil. | 20.89 | +3.10 % | 0.00 | - |
Facts & figures
Price data
| TRADE PLATFORM | Börse Stuttgart (XSTU) | |
| LAST PRICE | 0.705 G | 0 Units |
| PRICE DETERMINATION TIME | 07/21/2026 / 05:18:42 PM | |
| DAILY VOLUME (UNITS) | 0 | |
| DAILY HIGH / LOW | 0.71 | 0.695 |
| PREV. DAY'S PRICE | 0.695 | (07/20) |
| CHANGE DAY BEFORE | +0.01 | 1.44 % |
| 52 WEEK HIGH / LOW | 1.06 (12/15) | 0.0545 (09/11) |
Key Figures (in EUR)
| 2023 | 2024 | 2025 | 2026e | 2027e | |
|---|---|---|---|---|---|
EARNINGS PER SHARE | -0.32 | -0.36 | 0.02 | -0.18 | -0.13 |
DIVIDENDS PER SHARE | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
DIVIDEND YIELD IN % | 0.00 % | 0.00 % | 0.00 % | - | - |
DIVIDEND GROWTH IN % | - | - | - | - | - |
PRICE - EARNINGS RATIO | - | - | 45.74 | - | - |
PRICE - BOOK RATIO | 5.87 | 5.19 | 4.71 | - | - |
PRICE - SALES RATIO | 12.22 | 4.86 | 18.52 | - | - |
PRICE - CASH FLOW RATIO | - | - | - | - | - |
Master Data
| WKN | A3CRY2 |
| ISIN | GB00BMWLM973 |
| SYMBOL | 6UI |
| EXCHANGE SEGMENT | Freiverkehr |
| TYPE OF FINANCIAL INSTRUMENT | Equity |
| DENOMINATION | ARECOR THERAPEUTICS -,01 |
| INDEX MEMBERSHIP | - |
| TRADING SEGMENT | - |
| TRADING HOURS | 07:30:00 AM - 10:00:00 PM |
| TRADING CURRENCY | Euro |
| NOMINAL CURRENCY | - |
| SETTLEMENT CURRENCY | Euro |
| SECTOR AND INDUSTRY | Healthcare, Healthcare Services |
| NUMBER OF SHARES | - |
| MARKET CAPITALISATION | - |
Performance overview
| 1W | 1M | 3M | 6M | 1Y | 3Y | 5Y | YTD | |
|---|---|---|---|---|---|---|---|---|
| PERFORMANCE | 21.93 % | 32.38 % | -4.79 % | -3.47 % | 91.99 % | -68.12 % | -73.27 % | 2.96 % |
| HIGH | 0.71 | 0.71 | 0.87 | 1.01 | 1.06 | 2.36 | 5.20 | 1.05 |
| LOW | 0.53 | 0.53 | 0.52 | 0.52 | 0.05 | 0.05 | 0.05 | 0.52 |
Dividende
pro Aktie
ARECOR THERAPEUTICS -,01 does not deliver dividend information
Company profile
Arecor Therapeutics Plc is a biopharmaceutical company that targets improving patient care by bringing medicines to market through the enhancement of existing therapeutic products. It engages through proprietary formulation technology platform, Arestat, which develops an internal portfolio of proprietary products, as well as working with pharmaceutical and biotechnology companies to deliver reformulations of its partner's therapeutic products. The firm focuses on internal proprietary product development can be divided into following product classes: diabetes and specialty hospital care. The company was headquartered in Little Chesterford, the United Kingdom.
Analyst Rating
Ø-Target Price DistanceNot Available
Current Price
Not AvailableØ-Target Price
Not AvailableAverage ResultNot Available
Buy0
Overweight0
Hold0
Underweight 0
Sell0
Company Events
No company events available.